Does Chronic Cervicitis Cause Cervical Cancer or Raise Risk?
At a Glance
Chronic cervicitis is ongoing inflammation of the cervix and is not known to independently cause cervical cancer. Almost all cervical cancers are linked to persistent high-risk HPV, so follow-up depends on HPV results, cervical cell changes, symptoms, and your clinical history.
In this answer
4 sections
Chronic cervicitis is not known to independently turn into or cause cervical cancer [1]. The word “chronic” simply describes how long the inflammation has been present; it does not indicate how severe the condition is, nor does it mean it will become cancer. While it is natural to feel worried when you see “cervicitis” on a medical report, medical research shows that the established cause of almost all cervical precancers and cancers is a persistent infection with high-risk human papillomavirus (HPV) [2].
What is Chronic Cervicitis?
Chronic cervicitis is a general medical term for ongoing inflammation of the cervix. It is a separate condition from cervical cancer and precancer [3].
This inflammation can be caused by various factors, including:
- Sexually transmitted infections (STIs) such as chlamydia, gonorrhea, or trichomoniasis
- Other vaginal or cervical imbalances, such as bacterial vaginosis [4]
- Physical irritation from chemicals, douches, or friction
- Hormonal changes
Because cervicitis has many possible causes, your doctor may recommend a pelvic examination and specific testing (like STI swabs) to find the root cause. If an infection is identified, it can often be treated with targeted medication (such as antibiotics).
The Real Driver of Cervical Cancer: High-Risk HPV
While you can have chronic cervicitis and an HPV infection at the same time, the inflammation itself is not what drives cervical cancer [5].
Cervical cancer is almost always caused by high-risk strains of HPV (human papillomavirus) [2]. HPV is incredibly common, and most infections clear up on their own without causing any harm. However, in a minority of cases, high-risk HPV persists in the body for years [6]. This persistent infection can eventually cause healthy cervical cells to undergo abnormal, precancerous changes.
Other factors can influence this process. For example, smoking or having a condition that suppresses your immune system can make it much harder for your body to clear the virus, which increases the risk of an HPV infection persisting and progressing [7].
Deciphering Your Test Results
When you undergo cervical testing, you might encounter different types of reports. It is important to know that the wording on a Pap smear (a cytology test that looks at loose cells) is different from a tissue biopsy (a histopathology test that looks at a slice of tissue).
- Inflammation on a report: If your Pap or biopsy report notes inflammation or chronic cervicitis but states there is no evidence of dysplasia (abnormal cell growth) or malignancy, this means no precancerous or cancerous cells were seen in that specific sample [8] [9].
- CIN (Cervical Intraepithelial Neoplasia): This is a biopsy term for precancerous cell changes—it is not cancer [3].
- ASC-US: A Pap smear term meaning “atypical squamous cells of undetermined significance.” This means the cells look mildly unclear or slightly abnormal [10].
- LSIL and HSIL: Pap smear terms for low-grade and high-grade squamous intraepithelial lesions (cell changes) [10].
If you have abnormal cells on your Pap smear (like ASC-US, LSIL, or HSIL) or test positive for high-risk HPV, your care team will use established risk-based guidelines to determine your next steps [11]. Because a small biopsy only tests a tiny piece of tissue, your doctor will combine those results with your Pap, HPV test, and clinical history to ensure nothing else was missed [12]. This management is highly individualized and might involve repeat testing in a year, a closer look with a special magnifying instrument (colposcopy), or a biopsy [13].
Screening vs. Symptoms
Routine cervical screening (Pap smears and HPV testing) is designed for people without symptoms. Finding and treating HPV-induced precancer greatly reduces your chance of cervical cancer developing later in life [14].
However, screening does not replace the need to evaluate active symptoms. If you are experiencing concerning symptoms, you need a prompt clinical evaluation, even if your last Pap smear was normal [15].
Do not wait for your next routine screening if you experience any of the following:
- Contact your clinic soon for: Persistent bleeding after intercourse, spotting between periods, bleeding after menopause, or unusual/foul-smelling vaginal discharge.
- Seek urgent medical care for: Heavy vaginal bleeding, severe or rapidly worsening pelvic pain, fever, chills, or any of these symptoms if you are pregnant.
Common questions in this guide
Can chronic cervicitis develop into cervical cancer?
Does having cervicitis make cervical cancer more likely?
What does chronic cervicitis on a Pap smear or biopsy mean?
Does an abnormal Pap result mean I have cervical cancer?
What symptoms should I report if I have chronic cervicitis?
How is chronic cervicitis evaluated and treated?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Show more
Get notified when new evidence is published on chronic cervicitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Am I up to date with the HPV and Pap testing appropriate for my age and medical history?
- 2.What is the exact overall interpretation of my pathology or Pap report, and does it show any precancerous cellular changes?
- 3.Was my transformation zone (the area of the cervix where most abnormal changes occur) adequately sampled during my recent test?
- 4.Do my current symptoms suggest we should test for other specific infections, such as STIs, that might be causing my cervicitis?
- 5.Based on my overall risk profile, when exactly should my next follow-up appointment or screening take place?
References
References (15)
- 1
Epidemiological Investigation and Risk Factors for Cervical Lesions: Cervical Cancer Screening Among Women in Rural Areas of Henan Province China.
Zhang Q, Xie W, Wang F, et al.
Medical science monitor : international medical journal of experimental and clinical research 2016; (22()):1858-65 doi:10.12659/msm.894663.
PMID: 27249229 - 2
Innate immune response against HPV: Possible crosstalking with endocervical γδ T cells.
Dogan S, Terzioglu E, Ucar S
Journal of reproductive immunology 2021; (148()):103435 doi:10.1016/j.jri.2021.103435.
PMID: 34741834 - 3
Expressions of survivin, P16(INK4a), COX-2, and Ki-67 in cervical cancer progression reveal the potential clinical application.
Zhou WQ, Sheng QY, Sheng YH, et al.
European journal of gynaecological oncology 2015; (36(1)):62-8.
PMID: 25872337 - 4
The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis.
Norenhag J, Du J, Olovsson M, et al.
BJOG : an international journal of obstetrics and gynaecology 2020; (127(2)):171-180 doi:10.1111/1471-0528.15854.
PMID: 31237400 - 5
Oxidative Stress, Inflammation, and Antioxidant Strategies in Cervical Cancer-A Narrative Review.
Tomaziu-Todosia Anton E, Anton GI, Scripcariu IS, et al.
International journal of molecular sciences 2025; (26(10)) doi:10.3390/ijms26104961.
PMID: 40430101 - 6
Risk of cervical dysplasia among human papillomavirus-infected women in Korea: a multicenter prospective study.
Park Y, Kim TJ, Hwang CS, et al.
Journal of gynecologic oncology 2019; (30(3)):e50 doi:10.3802/jgo.2019.30.e50.
PMID: 30887765 - 7
Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies.
Bowden SJ, Doulgeraki T, Bouras E, et al.
BMC medicine 2023; (21(1)):274 doi:10.1186/s12916-023-02965-w.
PMID: 37501128 - 8
Cervical cytopathological changes in pregnancy: An experience from a low resource setting.
Rasheed FA, Yakasai IA, Takai IU, et al.
Annals of African medicine 2021; (20(3)):212-221 doi:10.4103/aam.aam_47_20.
PMID: 34558451 - 9
Correlation of Cervical Pap Smear with Biopsy in the Lesion of Cervix.
Dhakal R, Makaju R, Sharma S, et al.
Kathmandu University medical journal (KUMJ) 2016; (14(55)):254-257.
PMID: 28814689 - 10
Abnormal uterine cervical cytology in a large tertiary hospital in Bangkok metropolis: Prevalence, management, and outcomes.
Kingnate C, Tangjitgamol S, Khunnarong J, Manusirivithaya S
Indian journal of cancer 2016; (53(1)):67-73 doi:10.4103/0019-509X.180827.
PMID: 27146746 - 11
Risk-based guidelines: Redefining management of abnormal cervical cancer screening results.
Wiser A, Quinlan JD, Batur P
Cleveland Clinic journal of medicine 2021; (88(10)):556-560 doi:10.3949/ccjm.88a.20193.
PMID: 34598920 - 12
The Help of HPV Integration Testing to Avoid the Misdiagnosis of a Patient with Stage Ia1 Cervical Cancer: A Case Report and Literature Review.
Li J, Zhang X, Wang P, Li W
Pharmacogenomics and personalized medicine 2021; (14()):1457-1461 doi:10.2147/PGPM.S310345.
PMID: 34819743 - 13
Value of high‑risk human papillomavirus detection combined with colposcopy in the diagnosis of cervical cancer and precancerous lesions.
Wang P, Gao D, Yu X, Zhu G
Oncology letters 2024; (27(4)):185 doi:10.3892/ol.2024.14318.
PMID: 38476208 - 14
Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.
, Curry SJ, Krist AH, et al.
JAMA 2018; (320(7)):674-686 doi:10.1001/jama.2018.10897.
PMID: 30140884 - 15
The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.
Beyazit F, Sılan F, Gencer M, et al.
Ginekologia polska 2018; (89(2)):62-67 doi:10.5603/GP.a2018.0011.
PMID: 29512809
This page is for informational purposes only and does not constitute medical advice. A clinician should interpret your symptoms, cervical tests, and HPV results.